Total Payments
$11,558
2024 Payments
$5,547
Companies
22
Transactions
182
Medicare Patients
3,433
Medicare Billing
$957,596
Payment Breakdown by Category
Food & Beverage$8,053 (69.7%)
Consulting$1,515 (13.1%)
Travel$1,033 (8.9%)
Research$825.00 (7.1%)
Education$132.47 (1.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,053 | 174 | 69.7% |
| Consulting Fee | $1,515 | 1 | 13.1% |
| Travel and Lodging | $1,033 | 3 | 8.9% |
| Unspecified | $825.00 | 2 | 7.1% |
| Education | $132.47 | 2 | 1.1% |
Payments by Type
General
$10,733
180 transactions
Research
$825.00
2 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $2,280 | 18 | $0 (2024) |
| GlaxoSmithKline, LLC. | $2,142 | 51 | $0 (2024) |
| Pulmonx Corporation | $1,583 | 9 | $0 (2024) |
| Inspire Medical Systems, Inc. | $1,241 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,026 | 19 | $0 (2024) |
| SANOFI US SERVICES INC. | $825.00 | 2 | $0 (2022) |
| Insmed, Inc. | $730.30 | 19 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $583.37 | 13 | $0 (2024) |
| Amgen Inc. | $300.27 | 10 | $0 (2024) |
| Boston Scientific Corporation | $186.70 | 7 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $5,547 | 69 | GENZYME CORPORATION ($1,998) |
| 2023 | $2,850 | 55 | GlaxoSmithKline, LLC. ($905.89) |
| 2022 | $1,880 | 24 | SANOFI US SERVICES INC. ($825.00) |
| 2021 | $602.99 | 16 | GlaxoSmithKline, LLC. ($462.11) |
| 2020 | $483.70 | 13 | Insmed, Inc. ($372.42) |
| 2019 | $40.85 | 2 | Insmed, Inc. ($40.85) |
| 2018 | $137.95 | 2 | Novartis Pharmaceuticals Corporation ($124.99) |
| 2017 | $15.19 | 1 | PFIZER INC. ($15.19) |
All Payment Transactions
182 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $51.67 | General |
| Category: NEUROLOGY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $121.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/09/2024 | Baxter Healthcare | Hillrom - Vest System Model 105 Home Care (Device) | Food and Beverage | In-kind items and services | $27.89 | General |
| Category: Airway Clearance Device | ||||||
| 12/05/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $33.82 | General |
| Category: RESPIRATORY | ||||||
| 11/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $121.87 | General |
| Category: Respiratory | ||||||
| 11/14/2024 | Fisher & Paykel Healthcare Inc | FISHER & PAYKEL HEALTHCARE (Device), FISHER & PAYKEL HEALTHCARE, FISHER & PAYKEL HEALTHCARE | Food and Beverage | In-kind items and services | $32.53 | General |
| Category: Sleep | ||||||
| 11/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $32.61 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/07/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.91 | General |
| Category: RESPIRATORY | ||||||
| 10/31/2024 | SANOFI-AVENTIS U.S. LLC | DUPIXENT (Biological) | Education | In-kind items and services | $57.48 | General |
| Category: Immunology | ||||||
| 10/29/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.80 | General |
| Category: Inflammation | ||||||
| 10/22/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $28.56 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/18/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $33.89 | General |
| Category: Respiratory | ||||||
| 10/17/2024 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $21.00 | General |
| Category: Inflammation | ||||||
| 10/02/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,515.00 | General |
| 10/01/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $26.23 | General |
| Category: Respiratory | ||||||
| 09/17/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $22.67 | General |
| Category: Immunology | ||||||
| 09/13/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $137.09 | General |
| Category: NEUROLOGY | ||||||
| 09/13/2024 | Inspire Medical Systems, Inc. | INSPIRE (Device) | Food and Beverage | In-kind items and services | $24.32 | General |
| Category: NEUROLOGY | ||||||
| 09/13/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.09 | General |
| Category: Respiratory | ||||||
| 09/03/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $73.15 | General |
| 08/28/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $22.09 | General |
| Category: Respiratory | ||||||
| 08/21/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Respiratory | ||||||
| 08/05/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $22.42 | General |
| Category: Respiratory | ||||||
| 08/02/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: Respiratory | ||||||
| 07/31/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: RESPIRATORY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Randomized, Double-blind, Placebo-controlled, Parallel Group Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of SAR440340/REGN3500/Itepekimab (Anti-IL-33 mAb) in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) | SANOFI US SERVICES INC. | $825.00 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 590 | 1,120 | $352,527 | $148,021 |
| 2022 | 14 | 840 | 1,698 | $535,280 | $211,829 |
| 2021 | 13 | 1,053 | 2,590 | $844,914 | $351,086 |
| 2020 | 9 | 950 | 1,850 | $593,635 | $246,660 |
Total Patients
3,433
Total Services
7,258
Medicare Billing
$957,596
Procedure Codes
46
All Medicare Procedures & Services
46 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 187 | 433 | $177,097 | $79,715 | 45.0% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 187 | 368 | $102,672 | $37,400 | 36.4% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2023 | 102 | 190 | $34,580 | $17,828 | 51.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 22 | 36 | $10,557 | $4,868 | 46.1% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 15 | 15 | $7,190 | $2,379 | 33.1% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2023 | 24 | 24 | $12,072 | $1,809 | 15.0% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 11 | 11 | $4,133 | $1,628 | 39.4% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2023 | 12 | 12 | $2,304 | $1,550 | 67.3% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2023 | 17 | 17 | $1,462 | $664.70 | 45.5% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2023 | 13 | 14 | $459.76 | $180.32 | 39.2% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 266 | 632 | $258,488 | $119,577 | 46.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 280 | 656 | $183,024 | $55,809 | 30.5% |
| 99292 | Critical care, each additional 30 minutes | Facility | 2022 | 111 | 206 | $37,589 | $19,912 | 53.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 23 | 42 | $12,317 | $5,941 | 48.2% |
| 36556 | Insertion of non-tunneled central venous tube for infusion (5 years or older) | Facility | 2022 | 36 | 36 | $18,108 | $2,817 | 15.6% |
| 92950 | Manual attempt to restore blood circulation and breathing | Facility | 2022 | 12 | 13 | $12,454 | $1,809 | 14.5% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 13 | 13 | $2,496 | $1,717 | 68.8% |
| 99221 | Initial hospital inpatient care per day, typically 30 minutes | Facility | 2022 | 12 | 12 | $2,716 | $1,083 | 39.9% |
| 36569 | Insertion of tube for infusion (5 years or older) | Facility | 2022 | 11 | 11 | $2,394 | $953.31 | 39.8% |
| 36620 | Insertion of artery tube for blood sampling or infusion through skin | Facility | 2022 | 18 | 18 | $1,548 | $713.00 | 46.1% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 11 | 11 | $1,369 | $490.70 | 35.9% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 11 | 11 | $1,025 | $367.37 | 35.9% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 11 | 11 | $916.30 | $328.53 | 35.9% |
| 76937 | Ultrasonic guidance for blood vessel access | Facility | 2022 | 25 | 26 | $836.08 | $311.08 | 37.2% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 383 | 1,061 | $433,949 | $207,345 | 47.8% |
About Dr. Andrew Pastewski, MD
Dr. Andrew Pastewski, MD is a Pulmonary Disease healthcare provider based in Palmetto Bay, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2007. The National Provider Identifier (NPI) number assigned to this provider is 1427253236.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Andrew Pastewski, MD has received a total of $11,558 in payments from pharmaceutical and medical device companies, with $5,547 received in 2024. These payments were reported across 182 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($8,053).
As a Medicare-enrolled provider, Pastewski has provided services to 3,433 Medicare beneficiaries, totaling 7,258 services with total Medicare billing of $957,596. Data is available for 4 years (2020–2023), covering 46 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Palmetto Bay, FL
- Active Since 06/20/2007
- Last Updated 01/16/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1427253236
Products in Payments
- ZEPHYR ENDOBRONCHIAL VALVE (Device) $1,265
- TRELEGY ELLIPTA (Drug) $1,230
- DUPIXENT (Biological) $1,185
- INSPIRE (Device) $1,023
- Arikayce (Drug) $614.23
- FASENRA (Biological) $607.87
- TEZSPIRE (Biological) $386.41
- CHARTIS CATHETER (Device) $317.85
- NUCALA (Biological) $280.59
- Inspire Upper Airway Stimulation System (Device) $217.74
- AIRSUPRA (Drug) $203.56
- EXALT Model D (Device) $134.65
- AREXVY (Drug) $131.44
- ANDEXXA (Biological) $128.81
- ENTRESTO (Drug) $124.99
- Hillrom - Vest System Model 105 Home Care (Device) $80.58
- ELIQUIS (Drug) $56.12
- Hillrom - Life 2000 Ventilation System (Device) $50.68
- WAKIX (Drug) $46.13
- HYDROFERA BLUE (Device) $36.39
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Palmetto Bay
Dr. Fabriccio Letellier, M.d, M.D
Pulmonary Disease — Payments: $11,473
Pulmonary Disease $11,473
Natalia Loureiro, M.d, M.D
Pulmonary Disease — Payments: $3,741
Pulmonary Disease $3,741
Arkady Vaknansky, Md, MD
Pulmonary Disease — Payments: $1,610
Pulmonary Disease $1,610
Antonio Velez Perez, Md, MD
Pulmonary Disease — Payments: $113.33
Pulmonary Disease $113.33